Granules India board approves Rs 1,762.5 crore preferential fundraise

Marquee QIP investorFund Raising View source PDF Explain this filing

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.8%Reaction day

₹599.00

prior close

₹606.95

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%+2.4% vs market

Pharmaceuticals peers, median of 155sector+0.0%+2.8% vs sector

On the reaction day the stock moved 2.4 pts more than Nifty Smallcap 250 and 2.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.2

15m

-0.6

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.8+0.4+2.4+0.0+2.8

Next day

+2.3+0.5+1.8-0.2+2.5

+2.7+0.3+2.4-0.9+3.6

+0.6-0.2+0.8-1.6+2.2

-0.2-0.4+0.3-1.7+1.5

+0.3+0.7-0.4-1.0+1.3

+2.7+1.4+1.3+0.2+2.5

15d

-0.2-1.7+1.5-2.4+2.3

-5.8-7.6+1.8-7.9+2.2

-0.2-3.2+3.1-6.4+6.2

-2.1-14.1+12.0-14.4+12.3

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Granules India board approved raising up to Rs 1,762.5 crores via preferential issue. Includes up to 2.5 crore convertible warrants at Rs 585 each (Rs 1,462.5 crores) to promoter group and select investors, plus up to 51.28 lakh equity shares at Rs 585 each (Rs 300 crores) to non-promoter investors. Allottees include the Chigurupati family (promoters) and 360 ONE funds, plus Canada pension fund PSPIB. Warrants carry 25 percent upfront payment, convertible within 18 months. EGM on Jan 22, 2026.

Likely market impact

Significant equity dilution from promoter and new investor participation; PSPIB entry adds credibility. Subject to shareholder approval.